bioLOCKEY Healthworks

Healthcare

bioLOCKEY Healthworks is an innovative biotech company focused on point-of-care diagnostics and novel biologics. Their mission is to democratize and decentralize testing to personalize healthcare, making a significant impact on global health. This mission is particularly evident in their work in India, where they are delivering cervical cancer screenings across the country. Their unique selling point lies in their proprietary Nanobody tools, which form the foundation of their differentiated platforms. These tools enable them to develop novel diagnostic products. The company boasts a diverse and verified Nanobody Library, a Nanobody cellular Optimization platform, a Nanobody Discovery Platform (NanoDx), and a flexible vertical for Analytical development. These assets allow bioLOCKEY to target high-value medical challenges and optimize their solutions for greater affinity, potency, and developability. bioLOCKEY Healthworks sets itself apart from competitors through its commitment to biological innovation aimed at making the world safer, healthier, and more sustainable. They leverage the ingenuity and agility of India's start-up ecosystem to create disruptive technologies that pave the way to the future of health and wellbeing. This approach, combined with their multidisciplinary expertise and a fresh perspective, enables them to tackle some of the biggest R&D challenges in today’s healthcare landscape. The company is backed by various investors and partners, demonstrating confidence in their approach and potential. This support, along with their technological advancements and commitment to global health, positions bioLOCKEY Healthworks as a key player in the field of diagnostics and biologics.